行业多源确认
OpenAI 收购 Orchestra Bio，开发生命科学研究模型 Rosalind
精选理由
OpenAI 收购了做药物研发协作平台的 Orchestra Bio，要做 Rosalind 模型，看来和 Anthropic、Google 一样盯上了生命科学这块。
OpenAI 收购了 Orchestra Bio，一家帮助生物制药团队协调药物研发流程的平台公司。收购后 OpenAI 将围绕 Rosalind 模型和工具开展生命科学研究方向的开发。目前 Anthropic、OpenAI 和 Google 都把 AI 在生命科学的应用列为优先方向。
原文 · TestingCatalog
OpenAI ❤️ Orchestra Bio
> OpenAI has acquired Orchestra Bio to work on Rosalind models and tools for life sciences research.
> "Orchestra Bio is a platform that helps biopharma teams coordinate the complex process of drug development."
AI advancements in life sciences are probably one of the most desired areas for many. So far, it seems like a top priority for Anthropic, OpenAI, and Google.
